Approaching its 20th year of service, BioCentury Publications, Inc. is internationally recognized as the leading provider of biopharma business news, analysis and opinion covering corporate, emerging technology, partnering, clinical, regulation and public policy developments.

The company publishes the weekly journal BioCentury, The Bernstein Report on BioBusiness and BioCentury Extra, a daily online newspaper. BioCentury also publishes SciBX: Science - Business eXchange, a translational science journal in partnership with Nature Publishing Group, and markets BCIQ: BioCentury Online Intelligence, a data solutions product for biopharma industry and investment professionals.


The company is widely acknowledged in the life science corporate and investment communities for pioneering the creation of three annual conferences that provide turf-neutral venues for biopharma investors, pharmaceutical licensing professionals and corporate executives to conduct business.

BioCentury is headquartered in Redwood City, California, with offices in Washington, D.C., Chicago, Chadds Ford, Pennsylvania, and London. Its editorial and research staff comprise senior, industry-recognized business and science editors and writers.